Clinical Trials Browser

Phase 1 × Withdrawn × Imatinib Mesylate × Clear all

NCT00324077 2016-02-17

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

NCT02268435 2015-08-04

Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors

Phase 1 Withdrawn

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors